Farms.com Home   News

August 2025 SHIC eNewsletter

SHIC, FFAR, and Pork Checkoff Fund 10 H5N1 Risk to Swine Projects to Address Emerging Disease Threat

The Swine Health Information Center, in collaboration with the Foundation for Food & Agriculture Research and the Pork Checkoff, has recently funded 10 projects addressing research priorities and topics within its H5N1 Risk to Swine Research Program. Goals of the program are to enhance prevention, preparedness, mitigation, and response capabilities for H5N1 influenza in the US swine herd. The priority areas addressed through the funded projects include vaccine development and cross-protection, clinical presentation of pigs across different production phases, potential for mammary transmission, diagnostic surveillance, introduction and transmission risks, and biosecurity practices. The 10 new projects were initiated in summer 2025 and are 12 to 18 months in duration. Research outcomes from the funded projects will be shared with producers and veterinarians as soon as they become available.

The SHIC/FFAR/NPB H5N1 Risk to Swine Research Program request for proposals was announced on November 6, 2024, and received 51 proposals from 35 different institutions across six countries by the submission deadline of December 31, 2024. Proposals underwent a competitive review process across the first several months of 2025 by subject matter experts on influenza and the swine industry. Funding awarded across the 10 new projects totals $2.1 million of the $4 million total available for this program. Funding timely research is an essential component of SHIC providing project outcomes that drive action for emerging disease prevention, preparedness, mitigation, and response for the US swine industry.

SHIC/FFAR/NPB H5N1 Risk to Swine Research Program projects funded and initiated in response to the RFP include:

Click here to see more...

Trending Video

Matt Culbertson Joins Us: Inside PIC’s Historic FDA-Approved PRRS-Resistant Pig

Video: Matt Culbertson Joins Us: Inside PIC’s Historic FDA-Approved PRRS-Resistant Pig


Join us for an exclusive conversation with PIC as we explore the historic FDA approval of the first gene-edited PRRS-resistant pig. Discover what this milestone means for the future of pork production, how gene editing differs from traditional GMOs, and why this matters for both producers and consumers. We also dive into the potential $1.2 billion impact on global herd health and what’s next as PIC plans for a responsible international rollout.